Supplemental Table 1 from Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases
Year: 2023
Type: supplementary-materials
Abstract: Table S1. Summary of mutations present in the thyroid cancer cell lines and expression levels of differentiation markers. The table depicts known mutations in the six thyroid cancer cell lines we have utilized in our study. It also indicates the presence or absence (based on Ct values > 28) of thyroid differentiation markers in normal thyroid tissue, such as sodium-iodide symporter (NIS), thyroglobulin (Tg), and thyroid peroxidase (TPO) based on mRNA expression in these cell lines.
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361887240